DocuSign, Inc. (NASDAQ:DOCU) Position Boosted by Desjardins Global Asset Management Inc.

Desjardins Global Asset Management Inc. lifted its stake in shares of DocuSign, Inc. (NASDAQ:DOCU) by 60.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 966 shares of the company’s stock after purchasing an additional 364 shares during the period. Desjardins Global Asset Management Inc.’s holdings in DocuSign were worth $57,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Capital Analysts LLC boosted its position in DocuSign by 781.7% during the 4th quarter. Capital Analysts LLC now owns 529 shares of the company’s stock valued at $31,000 after purchasing an additional 469 shares during the period. Mackenzie Financial Corp boosted its holdings in shares of DocuSign by 90.7% during the fourth quarter. Mackenzie Financial Corp now owns 91,950 shares of the company’s stock valued at $5,466,000 after acquiring an additional 43,741 shares during the period. Harel Insurance Investments & Financial Services Ltd. boosted its holdings in shares of DocuSign by 9,284.4% during the fourth quarter. Harel Insurance Investments & Financial Services Ltd. now owns 39,039 shares of the company’s stock valued at $2,350,000 after acquiring an additional 38,623 shares during the period. NewEdge Wealth LLC bought a new position in shares of DocuSign during the fourth quarter worth about $667,000. Finally, Clarius Group LLC acquired a new stake in shares of DocuSign in the 4th quarter worth about $963,000. Institutional investors and hedge funds own 77.64% of the company’s stock.

Insiders Place Their Bets

In other news, Director Peter Solvik sold 15,000 shares of the stock in a transaction on Tuesday, April 9th. The stock was sold at an average price of $60.00, for a total transaction of $900,000.00. Following the completion of the sale, the director now owns 783 shares in the company, valued at approximately $46,980. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other DocuSign news, CEO Allan C. Thygesen sold 7,680 shares of the firm’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the transaction, the chief executive officer now directly owns 111,767 shares in the company, valued at $6,847,964.09. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Peter Solvik sold 15,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 9th. The shares were sold at an average price of $60.00, for a total transaction of $900,000.00. Following the sale, the director now owns 783 shares in the company, valued at approximately $46,980. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 54,871 shares of company stock worth $3,176,199. 17.80% of the stock is owned by insiders.

DocuSign Trading Down 2.3 %

Shares of DocuSign stock opened at $55.70 on Friday. DocuSign, Inc. has a 52 week low of $38.11 and a 52 week high of $64.76. The stock has a market cap of $11.44 billion, a PE ratio of 154.73, a price-to-earnings-growth ratio of 5.08 and a beta of 0.89. The company’s 50-day moving average price is $55.90 and its two-hundred day moving average price is $52.12.

DocuSign (NASDAQ:DOCU) last announced its quarterly earnings data on Thursday, March 7th. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.06. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. The company had revenue of $712.39 million for the quarter, compared to analysts’ expectations of $698.05 million. On average, equities analysts predict that DocuSign, Inc. will post 0.86 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a research report on Friday, April 12th. Royal Bank of Canada reissued a “sector perform” rating and issued a $59.00 price objective on shares of DocuSign in a report on Friday, April 12th. Morgan Stanley raised DocuSign from an “underweight” rating to an “equal weight” rating and lifted their target price for the company from $49.00 to $64.00 in a research note on Tuesday, January 16th. JMP Securities reissued a “market outperform” rating and issued a $84.00 price target on shares of DocuSign in a research note on Friday, April 12th. Finally, UBS Group upgraded shares of DocuSign from a “sell” rating to a “neutral” rating and lifted their price objective for the company from $48.00 to $62.00 in a research note on Friday, April 12th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, DocuSign presently has a consensus rating of “Hold” and an average price target of $60.25.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.